Redmile Group, LLC

Average Profitability
6.59%
Insider Buys Quantity
26
Insider Buys Sum
$542.83M
Insider Sells Quantity
3
Insider Sells Sum
$5.31M

Insider Activity of Redmile Group, LLC

According to the SEC Form 4 filings, Redmile Group, LLC, being in a position of

  1. director at Absci Corporation,
    оver the last 12 months, has bought 222222 shares for $999,999, and sold 0 shares,
    over all time since 2021-07-26, has bought 2097222 shares for $31M, and sold 0 shares.

The largest purchase of all time was on 2020-10-14 and amounted to 6882352 shares of Shattuck Labs, Inc. for $119.34M.

The largest sale of all time was on 2020-12-28 and amounted to 500000 shares of Aprea Therapeutics, Inc. for $2.79M.

Biography of Redmile Group, LLC

No biography is available at this moment.

2024-03-01PurchaseAbsci Corporation
ABSI
director
222,222
0.1982%
$4.50$999,999-19.72%
2023-12-26PurchaseFate Therapeutics, Inc.
FATE
44,630
0.0455%
$3.72$166,024+9.24%
2023-06-29SaleIGM Biosciences, Inc.
IGMS
director
80,423
0.1809%
$9.42$757,585-11.31%
2023-06-29PurchaseIGM Biosciences, Inc.
IGMS
director
80,423
0.1809%
$9.42$757,585-11.31%
2023-04-21PurchaseFate Therapeutics, Inc.
FATE
256,639
0.26%
$6.18$1.59M-27.09%
2023-04-20PurchaseFate Therapeutics, Inc.
FATE
20,000
0.0204%
$5.99$119,800-24.29%
2023-04-14SaleFate Therapeutics, Inc.
FATE
302,339
0.2996%
$5.84$1.77M-24.54%
2023-04-14PurchaseFate Therapeutics, Inc.
FATE
25,700
0.0262%
$6.00$154,200-24.54%
2022-10-13PurchaseZymeworks Inc.
ZYME
10 percent owner
30,481
0.0481%
$5.03$153,435+63.8%
2021-11-02PurchaseEntrada Therapeutics, Inc.
TRDA
10 percent owner
2M
25.0465%
$20.00$40M-53.61%
2021-07-26PurchaseAbsci Corporation
ABSI
director
1.88M
1.7426%
$16.00$30M-63.43%
2021-06-21PurchaseVerve Therapeutics, Inc.
VERV
10 percent owner
2.1M
13.5677%
$19.00$39.9M-7.41%
2021-01-08PurchaseFate Therapeutics, Inc.
FATE
327,485
0.2577%
$85.50$28M-33.06%
2020-12-28SaleAprea Therapeutics, Inc.
APRE
10 percent owner
500,000
2.4014%
$5.58$2.79M-11.73%
2020-10-14PurchaseShattuck Labs, Inc.
STTK
6.88M
40.0846%
$17.34$119.34M+49.69%
2020-09-09PurchaseIGM Biosciences, Inc.
IGMS
46,520
0.1508%
$52.55$2.44M+48.02%
2020-09-08PurchaseIGM Biosciences, Inc.
IGMS
94,226
0.3057%
$49.91$4.7M+56.01%
2020-09-04PurchaseIGM Biosciences, Inc.
IGMS
148,866
0.4846%
$50.28$7.48M+55.42%
2020-09-03PurchaseIGM Biosciences, Inc.
IGMS
148,506
0.4813%
$48.69$7.23M+59.76%
2020-09-02PurchaseIGM Biosciences, Inc.
IGMS
41,274
0.1318%
$46.68$1.93M+64.15%
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.